Description

Monalisa Soft with Lidocaine

Monalisa Soft is a professional injectable dermal filler formulated with cross-linked hyaluronic acid and lidocaine. It is the softest formulation within the Monalisa filler collection and is designed for subtle correction of superficial facial lines and delicate treatment areas.

Each prefilled syringe contains 1ml of transparent hyaluronic acid gel. Monalisa Soft contains 24mg/ml of cross-linked hyaluronic acid and 0.3% lidocaine. The incorporated lidocaine is intended to help improve patient comfort during administration.

Monalisa Soft is manufactured by Genoss Co., Ltd. in South Korea and must only be administered by appropriately qualified, trained and insured healthcare or aesthetic professionals.

What Is Monalisa Soft Used For?

Monalisa Soft is intended for the temporary correction of suitable superficial facial wrinkles in adult patients. Its refined gel characteristics make it suitable for professional treatments where controlled placement and subtle correction are required.

Depending on the patient’s anatomy, medical history and individual treatment plan, qualified practitioners may consider this product for superficial lines, delicate facial areas and selected lip-contouring treatments. The manufacturer’s product information identifies the superficial dermis as the recommended placement level.

A complete consultation and individual suitability assessment must always be conducted before treatment. The choice of product, treatment area, placement depth and technique remains the responsibility of the treating professional.

Monalisa Soft Product Specifications

• Product: Monalisa Soft with Lidocaine
• Product type: Injectable hyaluronic acid dermal filler
• Syringe volume: 1ml
• Hyaluronic acid concentration: 24mg/ml
• Lidocaine concentration: 0.3%
• Particle size: Approximately 200 micrometres
• Recommended placement: Superficial dermis
• Recommended needle: 30G thin-wall needle
• Manufacturer: Genoss Co., Ltd.
• Country of manufacture: South Korea
• Storage: 2°C to 25°C
• Use: Professional use only

Packaging configurations can differ between markets. Always check the outer carton to confirm the number and size of the supplied needles, composition, storage requirements, expiry date and applicable regulatory information.

Key Features of Monalisa Soft

• Soft cross-linked hyaluronic acid gel
• Designed for subtle correction of superficial facial lines
• Fine particle size within the Monalisa filler range
• Contains 0.3% lidocaine for improved treatment comfort
• Supplied in a sterile, ready-to-use prefilled syringe
• Ergonomically designed syringe for professional handling
• Manufactured using Monalisa Hy-BRID technology
• Intended for use by qualified professionals only

Cross-Linked Hyaluronic Acid

Hyaluronic acid is a substance naturally found within the human body. In dermal fillers, cross-linking helps the hyaluronic acid form a gel that can provide temporary physical support when it is appropriately placed within the tissue.

Monalisa Soft has a finer particle profile than the firmer products within the Monalisa collection. This makes it different from formulations intended for deeper placement or more substantial structural correction. A softer product should not automatically be considered suitable for every delicate area, however. Patient anatomy, tissue condition and clinical risk must always guide product selection.

Monalisa Soft Compared with Other Monalisa Fillers

The Monalisa Lidocaine collection includes Soft, Mild, Hard and Ultra formulations. These products have different particle sizes, gel characteristics and recommended placement levels.

• Soft: Approximately 200-micrometre particles for superficial placement
• Mild: Approximately 400-micrometre particles
• Hard: Approximately 600-micrometre particles
• Ultra: Approximately 900-micrometre particles for deeper professional applications

Monalisa Soft should therefore be selected for an appropriate superficial indication rather than as a substitute for a firmer volumising or structural filler. Practitioners must consult the current instructions supplied with the product before treatment.

Professional Consultation and Patient Assessment

Before administering Monalisa Soft, the practitioner should review the patient’s medical history, allergies, previous aesthetic procedures, current medication and treatment expectations. The intended treatment area should be assessed for infection, inflammation, active skin disease or other factors that could make treatment unsuitable.

The patient must receive an explanation of the expected outcome, limitations, aftercare requirements and possible adverse effects. Informed consent should be obtained and the product’s batch and traceability information should be recorded in the patient’s treatment notes.

Important Safety Information

Monalisa Soft must not be injected into blood vessels. Accidental intravascular administration of any dermal filler can cause serious complications, including vascular occlusion, tissue damage, visual disturbance, blindness or stroke. Administration requires detailed anatomical knowledge, aseptic technique and the ability to identify and manage complications promptly.

Do not use the product in patients with a known hypersensitivity to hyaluronic acid, lidocaine, amide-type local anaesthetics or another product component. Treatment should not be performed through areas affected by active infection, inflammation, rash, irritation, broken skin or an active cold-sore outbreak.

Pregnancy, breastfeeding, immune conditions, bleeding disorders, anticoagulant medication, a history of severe allergies and recent procedures in the same area require careful professional consideration. Consult the current manufacturer’s instructions for the complete contraindications, precautions and adverse-event information.

Possible Reactions

Expected injection-site reactions may include temporary redness, swelling, tenderness, bruising, itching, firmness or discolouration. Less common complications can be more serious and require urgent assessment. Patients should receive clear aftercare information and instructions explaining when and how to contact their treating practitioner.

Storage, Handling and Traceability

Store Monalisa Soft between 2°C and 25°C unless the packaging supplied with your product states otherwise. Protect the product from freezing, excessive heat and inappropriate environmental conditions.

Check the sterile packaging, syringe, batch number and expiry date before use. Do not use the product if its packaging is open or damaged, if it has expired, or if the gel appears abnormal. The syringe and supplied needles are single-use devices and must not be reused or resterilised. Dispose of used equipment in an approved clinical sharps container.

Order Monalisa Soft

Monalisa Soft with Lidocaine is available from The Clinic Vault for eligible professional purchasers. Customers are responsible for ensuring that they possess the training, qualifications, insurance and legal authority required to purchase and administer injectable aesthetic products.

Explore our professional aesthetic product collection or visit the Genoss instructions-for-use library for available manufacturer information.

Professional-use notice: This description provides general product information. It does not replace the instructions supplied with the product, accredited clinical training, professional judgement, local regulations or an individual patient assessment.